| Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label … D Sibbing, D Aradi, C Jacobshagen, L Gross, D Trenk, T Geisler, M Orban, ... The Lancet 390 (10104), 1747-1757, 2017 | 568 | 2017 |
| Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European … D Capodanno, T Gori, H Nef, A Latib, J Mehilli, M Lesiak, G Caramanno, ... EuroIntervention 10 (10), 1144-1153, 2015 | 542 | 2015 |
| Dual antiplatelet therapy after PCI in patients at high bleeding risk M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni, P Vranckx, Y Ozaki, ... New England Journal of Medicine 385 (18), 1643-1655, 2021 | 308 | 2021 |
| Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study J Escaned, C Collet, N Ryan, G Luigi De Maria, S Walsh, M Sabate, ... European heart journal 38 (42), 3124-3134, 2017 | 306 | 2017 |
| 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients … N Marx, M Federici, K Schütt, D Müller-Wieland, RA Ajjan, MJ Antunes, ... European heart journal 44 (39), 4043-4140, 2023 | 183 | 2023 |
| Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective C Tamburino, A Latib, RJ Van Geuns, M Sabate, J Mehilli, T Gori, ... EuroIntervention 11 (1), 45-52, 2015 | 180 | 2015 |
| Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events … L Ortega-Paz, D Capodanno, T Gori, H Nef, A Latib, G Caramanno, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2017 | 132 | 2017 |
| A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions P Généreux, I Kumsars, M Lesiak, A Kini, G Fontos, T Slagboom, I Ungi, ... Journal of the American College of Cardiology 65 (6), 533-543, 2015 | 127 | 2015 |
| Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial … S Grajek, M Popiel, L Gil, P Bręborowicz, M Lesiak, R Czepczyński, ... European heart journal 31 (6), 691-702, 2010 | 117 | 2010 |
| Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases M Karaźniewicz-Łada, D Danielak, P Burchardt, Ł Kruszyna, A Komosa, ... Clinical pharmacokinetics 53, 155-164, 2014 | 103 | 2014 |
| Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups G Gelbenegger, M Postula, L Pecen, S Halvorsen, M Lesiak, ... BMC medicine 17, 1-16, 2019 | 96 | 2019 |
| The impact of post-procedural asymmetry, expansion, and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in … P Suwannasom, Y Sotomi, Y Ishibashi, R Cavalcante, FN Albuquerque, ... Cardiovascular Interventions 9 (12), 1231-1242, 2016 | 93 | 2016 |
| Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy A Araszkiewicz, S Darocha, A Pietrasik, R Pietura, S Jankiewicz, ... International journal of cardiology 278, 232-237, 2019 | 85 | 2019 |
| Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study AP Banning, P Serruys, GL De Maria, N Ryan, S Walsh, N Gonzalo, ... European Heart Journal 43 (13), 1307-1316, 2022 | 80 | 2022 |
| Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention A Araszkiewicz, S Grajek, M Lesiak, M Prech, M Pyda, M Janus, ... The American journal of cardiology 98 (6), 725-728, 2006 | 73 | 2006 |
| Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric study S Grajek, M Lesiak, M Pyda, M Zajac, ST Paradowski, E Kaczmarek European heart journal 14 (1), 40-47, 1993 | 73 | 1993 |
| Comparison of angiographically guided direct stenting technique with direct stenting and optimal balloon angioplasty guided with intravascular ultrasound. The multicenter … RJ Gil, T Pawłowski, D Dudek, G Horszczaruk, K Żmudka, M Lesiak, ... American Heart Journal 154 (4), 669-675, 2007 | 67 | 2007 |
| New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary … M Grygier, A Araszkiewicz, M Lesiak, M Janus, J Kowal, W Skorupski, ... The American journal of cardiology 107 (8), 1131-1135, 2011 | 66 | 2011 |
| Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey M Valgimigli, F Costa, R Byrne, M Haude, A Baumbach, S Windecker, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2015 | 61 | 2015 |
| Heart failure with preserved ejection fraction—a concise review DM Adamczak, MT Oduah, T Kiebalo, S Nartowicz, M Bęben, M Pochylski, ... Current cardiology reports 22, 1-12, 2020 | 60 | 2020 |
